The EACH Coalition submitted comments to the MD PDAB in response to requested input on COMAR 14.01.05 (Policy Review, Final Action, Upper Payment Limits). The letter urged the board to […]
The Rare Access Action Project (RAAP) is an ad hoc coalition advocating for solutions to rare disease patient access in health care. Consisting of patient advocates, emerging life science companies,
The EACH Coalition submitted comments to the stakeholder council providing input on the Maryland Upper Payment Limit Action Plan ahead of the November 4th council meeting The letter urged the
The EACH Coalition submitted comments to the board providing input on the Maryland Upper Payment Limit Action Plan ahead of the October 28th board meeting The letter urged the board
The EACH Coalition submitted comments to the Colorado board on the updated redline versions of the affordability rule and policy and procedures prior to the October 18 board meeting. The
During the EACH Coalition monthly meeting for October, Aimed Alliance provided an update on their work around PDABs and highlighted several resources that are available on their website. Their update
The EACH Coalition submitted comments ahead of the Stakeholder Meeting held on September 24th urging for increased patient engagement and calling attention to shortcomings in the redlined Affordability Review Rule.
As the Washington PDAB reviews its drug review process, the EACH Coalition submitted comments to the board outlining concerns with drug reviews and outlining ways to improve the process and
In response to the Maryland PDAB’s request for comments on their draft plan on Upper Payment Limits, the EACH Coalition submitted comments to the board outlining recommendations to address concerns
As the Oregon PDAB reviews its drug review process, the EACH Coalition submitted comments to the board outlining concerns with drug reviews and outlining ways to improve the process and
